Authors: Pichler, R Maschek, W Hatzl-Griesenhofer, M Huber, H Wimmer, G Wahl, G Fridrik, M

Citation: R. Pichler et al., Clinical value of FDG hybrid-PET in staging and restaging of malignant lymphoma - compared with conventional diagnostic methods, NUKLEARMED, 39(6), 2000, pp. 166-173

Authors: Duba, HC Peter, S Hilbe, W Fluckinger, T Fridrik, M Erdel, M Thaler, J Utermann, G

Citation: Hc. Duba et al., Monitoring of remission status by fluorescence in situ hybridisation in chronic myeloid leukaemia patients treated with interferon-alpha, INT J ONCOL, 14(1), 1999, pp. 145-150

Authors: Hausmaninger, H Moser, R Samonigg, H Mlineritsch, B Schmidt, H Pecherstorfer, M Fridrik, M Kopf, C Nitsche, D Kaider, A Ludwig, H

Citation: H. Hausmaninger et al., Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon-alpha-2c in patients with advanced colorectal cancer: Final resultsof a randomised phase III study, EUR J CANC, 35(3), 1999, pp. 380-385

Authors: Kucera, E Speiser, P Gnant, M Szabo, L Samonigg, H Hausmaninger, H Mittlbock, M Fridrik, M Seifert, M Kubista, E Reiner, A Zeillinger, R Jakesz, R

Citation: E. Kucera et al., Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients, EUR J CANC, 35(3), 1999, pp. 398-405

Authors: Jakesz, R Hausmaninger, H Haider, K Kubista, E Samonigg, H Gnant, M Manfreda, D Tschurtschenthaler, G Kolb, R Stierer, M Fridrik, M Mlineritsch, B Steindorfer, P Mittlbock, M Steger, G

Citation: R. Jakesz et al., Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer, J CL ONCOL, 17(6), 1999, pp. 1701-1709

Authors: Jakesz, R Hausmaninger, H Samonigg, H Kubista, E Haider, K Mlineritsch, B Schmid, M Tausch, C Reiner, G Renner, K Stierer, M Jatzko, G Hofbauer, F Fridrik, M Schennach, W Sevelda, P Dadak, C Haid, A Scholz, R Lenzhofer, P Steindorfer, P Berger, A Mischinger, HJ

Citation: R. Jakesz et al., Trials of the Austrian Breast Cancer Group (ABC), ZBL CHIR, 123, 1998, pp. 28-32